Takuya Owari

1.7k total citations
56 papers, 619 citations indexed

About

Takuya Owari is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Takuya Owari has authored 56 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 25 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Takuya Owari's work include Bladder and Urothelial Cancer Treatments (24 papers), Prostate Cancer Treatment and Research (13 papers) and Urinary and Genital Oncology Studies (12 papers). Takuya Owari is often cited by papers focused on Bladder and Urothelial Cancer Treatments (24 papers), Prostate Cancer Treatment and Research (13 papers) and Urinary and Genital Oncology Studies (12 papers). Takuya Owari collaborates with scholars based in Japan, United States and China. Takuya Owari's co-authors include Yasushi Nakai, Kiyohide Fujimoto, Makito Miyake, Shunta Hori, Nobumichi Tanaka, Satoshi Anai, Yosuke Morizawa, Kazumasa Torimoto, Tomomi Fujii and Yoshitaka Itami and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Takuya Owari

51 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takuya Owari Japan	14	275	198	194	154	81	56	619
Kota Iida Japan	11	228 0.8×	165 0.8×	113 0.6×	116 0.8×	69 0.9×	38	441
Toshiaki Shinka Japan	12	224 0.8×	127 0.6×	169 0.9×	161 1.0×	75 0.9×	33	554
Nicole Izykowski Germany	12	112 0.4×	130 0.7×	182 0.9×	115 0.7×	82 1.0×	14	548
Qiang He China	16	361 1.3×	216 1.1×	155 0.8×	140 0.9×	82 1.0×	75	819
Shaobin Ni China	13	205 0.7×	88 0.4×	204 1.1×	196 1.3×	47 0.6×	22	603
Christoph Ausch Austria	13	237 0.9×	252 1.3×	99 0.5×	209 1.4×	40 0.5×	29	660
Morihiro Watanabe Japan	16	194 0.7×	234 1.2×	116 0.6×	158 1.0×	205 2.5×	33	669
Xiaoyong Zheng China	11	276 1.0×	139 0.7×	116 0.6×	185 1.2×	15 0.2×	22	488
Adnan Ali United Kingdom	12	87 0.3×	136 0.7×	273 1.4×	171 1.1×	34 0.4×	36	624
Naoko Arichi Japan	13	112 0.4×	154 0.8×	252 1.3×	198 1.3×	18 0.2×	31	591

Countries citing papers authored by Takuya Owari

Since Specialization

Citations

This map shows the geographic impact of Takuya Owari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Owari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Owari more than expected).

Fields of papers citing papers by Takuya Owari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Owari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Owari. The network helps show where Takuya Owari may publish in the future.

Co-authorship network of co-authors of Takuya Owari

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Owari. A scholar is included among the top collaborators of Takuya Owari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Owari. Takuya Owari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimizu, Takuto, Tomoya Ueda, Kazuki Yamamoto, et al.. (2025). Clinical Utility of Ureteral Optical Coherence Tomography for T Staging of Ureteral Cancer: NOCTURN Study. Journal of Endourology. 39(12). 1276–1284.

Miyake, Makito, Yuki Oda, Tatsuki Miyamoto, et al.. (2024). Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors. Scientific Reports. 14(1). 23128–23128.

Mori, Shiori, Ryoichi Nishida, Shingo Kishi, et al.. (2023). 5-Aminolevrinic Acid Exhibits Dual Effects on Stemness in Human Sarcoma Cell Lines under Dark Conditions. International Journal of Molecular Sciences. 24(7). 6189–6189. 4 indexed citations

Miyake, Makito, Nobutaka Nishimura, Sayuri Ohnishi, et al.. (2023). Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer. Cancers. 15(9). 2565–2565. 5 indexed citations

Kuwada, Masaomi, Shingo Kishi, Rina Fujiwara‐Tani, et al.. (2022). Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer. International Journal of Molecular Sciences. 23(12). 6516–6516. 11 indexed citations

Owari, Takuya, Nobumichi Tanaka, Yasushi Nakai, et al.. (2022). 5-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells. British Journal of Cancer. 127(2). 350–363. 32 indexed citations

Tsumura, Hideyasu, Nobumichi Tanaka, Takuya Owari, et al.. (2022). Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancer. Scientific Reports. 12(1). 11023–11023. 5 indexed citations

Tsumura, Hideyasu, Nobumichi Tanaka, Takuya Owari, et al.. (2022). Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer. Radiation Oncology. 17(1). 71–71. 3 indexed citations

Miyake, Makito, Nobutaka Nishimura, Takashi Inoue, et al.. (2021). Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Trials. 22(1). 136–136. 5 indexed citations

10.

Tanaka, Nobumichi, Yasushi Nakai, Isao Asakawa, et al.. (2021). Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil. International Journal of Urology. 28(11). 1171–1176. 3 indexed citations

11.

Itami, Yoshitaka, Makito Miyake, Takuya Owari, et al.. (2021). Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study. BMC Urology. 21(1). 10–10. 3 indexed citations

12.

Miyake, Makito, Yasushi Nakai, Nobutaka Nishimura, et al.. (2021). Hexylaminolevulinate‐mediated fluorescent urine cytology with a novel automated detection technology for screening and surveillance of bladder cancer. British Journal of Urology. 128(2). 244–253. 6 indexed citations

13.

Miyake, Makito, Yoshihiro Tatsumi, Shunta Hori, et al.. (2020). Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model. Asian Pacific Journal of Cancer Prevention. 21(12). 3743–3749. 4 indexed citations

14.

Owari, Takuya, Makito Miyake, Yasushi Nakai, et al.. (2020). External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy. Journal of bone oncology. 26. 100344–100344. 8 indexed citations

15.

Miyake, Makito, Nobutaka Nishimura, Katsuya Aoki, et al.. (2020). Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer. World Journal of Surgical Oncology. 18(1). 104–104. 6 indexed citations

16.

Miyake, Makito, Daisuke Gotoh, Yoshiaki Matsumura, et al.. (2019). The diagnostic utility of retroperitoneoscopic tissue biopsy for unresectable retroperitoneal lesions excluding urogenital cancers. World Journal of Surgical Oncology. 17(1). 35–35. 3 indexed citations

17.

Miyake, Makito, Nobumichi Tanaka, Isao Asakawa, et al.. (2018). The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions. Prostate International. 7(2). 47–53. 13 indexed citations

18.

Miyake, Makito, Takuya Owari, Shunta Hori, Yasushi Nakai, & Kiyohide Fujimoto. (2018). Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma. Research and Reports in Urology. Volume 10. 251–261. 31 indexed citations

19.

Owari, Takuya, Makito Miyake, Yasushi Nakai, et al.. (2018). A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma. Anticancer Research. 38(5). 3097–3103. 10 indexed citations

20.

Miyake, Makito, Takuya Owari, Takashi Iwamoto, et al.. (2017). Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy. Supportive Care in Cancer. 26(4). 1077–1086. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact